Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastoma.

Neurooncol Adv · 2021 · PMC8134527 · PMID 34042101

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

36 comparing TTF with a wide range of chemotherapy agents did not show statistical significance for improving either PFS or OS, but showed a trend toward improved outcomes.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.